Medtronic plc’s MDT growth is backed by remarkable progress within the Neurosurgery Portfolio. The company’s continuous ...

Axonics says that its device significantly reduces the user's need to recharge as it marks its second clearance in only a ...

The QPAN® Model, or QEEG-Guided Personalised AI-Based Neuromodulation and Rehabilitation, is an innovative therapeutic ...

Analyst reviews BrainsWay's rising share price and recent $20 million private placement, speculating on potential M&A plans ...

Approximately 10% to 20% of total knee arthroplasty (TKA) patients have persistent postoperative pain. Data from a new ...

NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq:HSDT) has announced promising preliminary findings from its PoNSTEP study, which evaluates the impact of adherence to the Portable ...

Theranica, a prescribed neuromodulation therapeutics company, today announced Medicaid coverage for the Nerivio® REN wearable ...

Remedee Labs, a startup based in Paris, France, has received a European approval for its device-based approach to treating ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Kamran Ansari invented a groundbreaking neuromodulation device and co-founded a medical tech startup with his sister, Nadia ...

A team of researchers has developed a soft cortical device that could revolutionize the treatment of epilepsy and other ...

Axonics announced today that it received regulatory approval in Australia for its R20 rechargeable sacral neuromodulation ...